Article info

Download PDFPDF

Strong expression of the neuronal transcription factor FOXP2 is linked to an increased risk of early PSA recurrence in ERG fusion-negative cancers
Free

Authors

  1. Correspondence to Uwe Michl, Martini-Clinic, Prostate Cancer Center, University Medical Center, 20246, Hamburg-Eppendorf, Germany; michl{at}uke.de
View Full Text

Citation

Stumm L, Burkhardt L, Steurer S, et al
Strong expression of the neuronal transcription factor FOXP2 is linked to an increased risk of early PSA recurrence in ERG fusion-negative cancers

Publication history

  • Received November 6, 2012
  • Revised December 31, 2012
  • Accepted February 4, 2013
  • First published April 4, 2013.
Online issue publication 
June 21, 2013

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.